Adipocytokines are associated with renal function in patients with normal range glomerular filtration rate and type 2 diabetes

Cytokine

Volumn 46, Issue 1, 2009, Pages 142-145

  Barlovic, Drazenka Pongrac ^a   Zaletel, Jelka ^a   Prezelj, Janez ^a  

^a UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

Author keywords

Adiponectin; Albuminuria; Glomerular filtration rate; Leptin; Type 2 diabetes

Indexed keywords

ADIPONECTIN; CREATININE; LEPTIN;

ADULT; ALBUMINURIA; ARTICLE; CONTROLLED STUDY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN URINE LEVEL;

ADIPOCYTES; ADIPONECTIN; AGED; ALBUMINURIA; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; DOUBLE-BLIND METHOD; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY; LEPTIN; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 62749177246     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2009.01.001     Document Type: Article

References (32)

1. Lau D.C., Dhillon B., Yan H., Szmitko P.E., and Verma S. Adipokines: molecular links between obesity and atherosclerosis. Am J Physiol Heart Circ Physiol 288 (2005) 2031-2041
2. Goldstein B., and Scalia R. Adiponectin: a novel adipokine linking adipocytes and vascular function. J Clin Endocrinol Metab 89 (2004) 2563-2568
3. Wolf G., Chen S., Han D.C., and Ziyadeh F.N. Leptin and renal disease. Am J Kidney Dis 39 (2002) 1-11
4. Wolf G., and Ziyadeh F.N. Leptin and renal fibrosis. Contrib Nephrol 151 (2006) 175-183
5. Merabet E., Dagogo-Jack S., Coyne D.W., Klein S., Santiago J.V., Hmiel S.P., et al. Increased plasma leptin concentrations in end-stage renal disease. J Clin Endocrinol Metab 82 (1997) 847-850
6. Zoccali C., Mallamaci F., and Tripepi G. Adipose tissue as a source of inflammatory cytokines in health and disease: focus on end-stage renal disease. Kidney Internat 63 Suppl. 84 (2003) S65-S68
7. Young G.A., Woodrow G., Kendall S., Oldroyd B., Turney J.H., Brownjohn A.M., et al. Increased plasma leptin/fat ratio in patients with chronic renal failure: a cause of malnutrition?. Nephrol Dial Transplant 12 (1997) 2318-2323
8. Fruehwald-Schultes B., Kern W., Beyer J., Forst T., Pfuetzner A., and Peters A. Elevated serum leptin concentrations in type 2 diabetic patients with microalbuminuria and macroalbuminuria. Metabolism 48 (1999) 1290-1293
9. Verrotti A., Basciani F., De Simone M., Morgese G., and Chiarelli F. Serum leptin changes during weight loss in obese diabetic subjects with and without microalbuminuria. Diabetes Nutr Metab 14 (2001) 283-287
10. Ouchi N., Kihara S., Arita Y., Maeda K., Kuriyama H., Okamoto Y., et al. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation 100 (1999) 2473-2476
11. Ouchi N., Kihara S., Arita Y., Nishida M., Matsuyama A., Okamoto Y., et al. Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages. Circulation 103 (2001) 1057-1063
12. Zoccali C., Mallamaci F., Tripepi G., Benedetto F.A., Cutrupi S., Parlongo S., et al. Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. J Am Soc Nephrol 13 (2002) 134-141
13. Looker H., Krakoff J., Funahashi T., Matsuzawa Y., Tanaka S., et al. Adiponectin concentrations are influenced by renal function and diabetes duration in Pima Indians with type 2 diabetes. J Clin Endocrinol Metab 89 (2004) 4010-4017
14. Koshimura J., Fujita H., Narita T., Shimotomai T., Hosoba M., Yoshioka N., et al. Urinary adiponectin excretion is increased in patients with overt diabetic nephropathy. Biochem Biophys Res Commun 316 (2004) 165-169
15. Komaba H., Igaki N., Goto S., Yokota K., Doi H., Takemoto T., et al. Increased serum high-molecular-weight complex of adiponectin in type 2 diabetic patients with impaired renal function. Am J Nephrol 26 (2006) 476-482
16. Yaturu S., Reddy R.D., Rains J., and Jain S.K. Plasma and urine levels of resistin and adiponectin in chronic kidney disease. Cytokine 37 1 (2007) 1-5
17. Malyszko J., Malyszko J.S., Brzosko S., Wolczynski S., and Mysliwiec M. Adiponectin is related to CD146, a novel marker of endothelial cell activation/injury in chronic renal failure and peritoneally dialyzed patients. J Clin Endocrinol Metab 89 (2004) 4620-4627
18. Gaspari F., Perico N., Ruggenenti P., Mosconi L., Amuchastequi C.S., Guerini E., et al. Plasma clearance of nonradioactive iohexol as a measure of glomerular filtration rate. J Am Soc Nephrol 6 (1995) 257-263
19. Zeng J., Patterson B.W., Klein S., Martin D.R., Dagogo-Jack S., Kohrt W.M., et al. Whole body leptin kinetics and renal metabolism in vivo. Am J Physiol 273 (1997) E1102-E1106
20. Cumin F., Baum H.P., and Levens N. Mechanism of leptin removal from the circulation by the kidney. J Endocrinol 155 (1997) 577-585
21. Hama H., Saito A., Takeda T., Tanuma A., Xie Y., Sato K., et al. Evidence indicating that renal tubular metabolism of leptin is mediated by megalin but not by the leptin receptors. Endocrinology 145 (2004) 3935-3940
22. Meyer C., Robson D., Rackovsky N., Nadkarni V., and Gerich J. Role of the kidney in human leptin metabolism. Am J Physiol 36 (1997) E903-E907
23. Sharma K., Considine R., Michael B., Dunn S., Weisberg L., Kurnik B., et al. Plasma leptin is partially cleared by the kidney and is elevated in hemodialysis patients. Kidney Int 51 (1997) 1980-1985
24. Chorostowska-Wynimko J., Plywaczewski R., Jonczak L., Bednarek M., Stepniewska A., Borowska A., et al. Leptin measurement in urine is a reliable method of monitoring its secretion in patients with obstructive sleep apnea syndrome. J Physiol Pharmacol 58 Suppl. 5 (2007) S105-S115
25. Thomson S.C., Vallon V., and Blantz R.C. Kidney function in early diabetes: the tubular hypothesis of glomerular filtration. Am J Physiol Renal Physiol 286 (2004) F8-F15
26. Tsioufis C., Dimitriadis K., Chatzis D., Vasiliadou C., Tousoulis D., Papademetriou V., et al. Relation of microalbuminuria to adiponectin and augmented C-reactive protein levels in men with essential hypertension. Am J Cardiol 96 (2005) 946-951
27. Sharma K., RamachandraRao S., Qiu G., Kataoka Usui H., Zhu Y., Dunn S.R., et al. Adiponectin regulates albuminuria and podocyte function in mice. J Clin Investig 118 (2008) 1645-1656
28. Guebre-Egziabher F., Bernhard J., Funahashi T., Hadj-Aissa A., and Fouque D. Adiponectin in chronic kidney disease is related more to metabolic disturbances than to decline in renal function. Nephrol Dial Transplant 20 (2005) 129-134
29. Zoccali C., Mallamaci F., Panuccio V., Tripepi G., Cutrupi S., Parlongo S., et al. Adiponectin is markedly increased in patients with nephrotic syndrome and is related to metabolic risk factors. Kidney Int 63 Suppl. 84 (2003) S98-S102
30. Lin J., Hu F.B., and Curhan G. Serum adiponectin and renal dysfunction in men with type 2 diabetes. Diabetes Care 30 (2007) 239-244
31. Risch L., Saely C., Hoefle G., Rein P., Langer P., Gouya G., et al. Relationship between glomerular filtration rate and the adipokines adiponectin, resistin and leptin in coronary patients with predominantly normal or mildly impaired renal function. Clin Chem Acta 376 (2007) 108-113
32. Rovin B.H., Song H., Hebert L.A., Nadasdy T., Nadasdy G., Birmingham D.J., et al. Plasma, urine, and renal expression of adiponectin in human systemic lupus erythematosus. Kidney Int 68 (2005) 1825-1833